iBio (IBIO) Prepaid Assets (2011 - 2026)

iBio's (IBIO) quarterly Prepaid Assets came in at $2.5 million in Q1 2026, up 122.89% year-on-year from $1.1 million in Q1 2025, and up 266.27% on a QoQ basis from $670000.0 in Q4 2025.

iBio (IBIO) Prepaid Assets (2011 - 2026) Analysis & Trends

iBio (IBIO) has 16 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 122.89% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 122.89% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 38.05% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $2.5 million, up from $670000.0 in the prior quarter.
  • Over the last five years, Prepaid Assets for IBIO reached as high as $2.5 million in Q1 2026 and fell as low as $414000.0 in Q4 2022.
  • Historically, Prepaid Assets has averaged $1.1 million across 5 years, with a median of $921000.0 in 2023.
  • Across the five-year window, Prepaid Assets tumbled 85.83% in 2022 and soared 122.89% in 2026, its largest moves.
  • Year by year, Prepaid Assets stood at $414000.0 in 2022, then soared by 115.94% to $894000.0 in 2023, then jumped by 40.6% to $1.3 million in 2024, then sank by 46.7% to $670000.0 in 2025, then soared by 266.27% to $2.5 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $2.5 million in Q1 2026, $670000.0 in Q4 2025, and $1.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 iBio 172.22 Mn 172.22 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.45 Mn
Dec 31, 2025 670,000.00
Sep 30, 2025 1.14 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 1.10 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 667,000.00
Jun 30, 2024 749,000.00
Mar 31, 2024 862,000.00
Dec 31, 2023 894,000.00
Sep 30, 2023 451,000.00
Jun 30, 2023 664,000.00
Mar 31, 2023 921,000.00
Dec 31, 2022 414,000.00
Sep 30, 2022 1.15 Mn
Jun 30, 2022 1.55 Mn
Mar 31, 2022 2.35 Mn
Dec 31, 2021 2.92 Mn
Sep 30, 2021 1.65 Mn
Jun 30, 2021 2.07 Mn